Navigation Links
EBRT reduces risk of subsequent mastectomy in patients with invasive breast cancer
Date:1/29/2014

p>

The February 1 print edition of the Red Journal also contains two editorials addressing breast brachytherapy and examining the data from this study. Peter Y. Chen, MD, a radiation oncologist at William Beaumont Health System in Royal Oak, Mich., emphasizes the need to ensure guidelines keep up with changing data. Robert R. Kuske, MD, a radiation oncologist at Arizona Breast Cancer Specialists in Scottsdale, Ariz., and S. Stanley Young, PhD, the assistant director for bioinformatics at the National Institute of Statistical Sciences, explore the reported differences between breast brachytherapy and whole breast irradiation from the statistical and clinical implications.


'/>"/>

Contact: Brittany Ashcroft
press@astro.org
703-839-7336
American Society for Radiation Oncology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Exciting New Eye Gel Debuts at Sublime Beauty®: Face Whisperer® Advanced Eye Gel Reduces Dark Circles, Bags and Wrinkles
2. 3-D mammography increases cancer detection and reduces call-back rates, Penn study finds
3. Breast tomosynthesis increases cancer detection and reduces recall rates
4. 3D mammography increases cancer detection and reduces call-back rates, Penn study finds
5. Blocking antioxidants in cancer cells reduces tumor growth in mice
6. Involving patients in their nurses shift change reduces medical errors and satisfies patients
7. North Carolina Municipality Reduces Man Power by Streamlining City Departmental Transaction Processes with Integrated Document Management by Altec
8. New Technology by MinuteHound Reduces Payroll Fraud in Emergency Rooms
9. New study shows spironolactone reduces heart failure hospitalizations, but not mortality
10. Dr. Kathy Gohar Introduces a New Dysport Procedure from Her Spa in Los Angeles That Reduces the Signs of Aging
11. Barnes-Jewish Hospital Research Shows Program Reduces Compassion Fatigue in Caregivers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... The decision to relocate US Sports Football ... to make camp more accessible to campers outside of the ... Football Camp. The fields are in premier condition and the ... Mike de Surville, vice president of US Sports Camps. “In ... coaches with the passion to create a program that makes ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 With Spring’s wet ... keep the condition of their crawl spaces in mind. The ... of the most common FAQs regarding crawl space conditions and ... an answer to owners that are confused as to how ... that, “One of the most common ways is through cracks ...
(Date:2/27/2015)... Oklahoma (PRWEB) February 27, 2015 ... by the U.S. Drug Enforcement Agency (DEA). ... local organizations continue to utilize the “Take-Back” guidelines ... by the FDA. , Eufaula Prescription Drug Disposal ... 1425 Industrial Drive in Eufaula, Oklahoma as the ...
(Date:2/27/2015)... According to a Feb. 12, 2015 ... used to treat cancer by killing cancer stem cells, has ... Administration (FDA) for use in the treatment of mesothelioma.* According ... FDA to encourage the development of drugs for the treatment ... the FDA’s decision,” said Melinda Helbock, Founder of The Law ...
(Date:2/27/2015)... 2015 The report analyzes the primary ... global celiac disease market. It also assesses key players ... activities, and investments. , Celiac disease is an autoimmune ... small intestine. Celiac disease often has a genetic predisposition. ... is affected by celiac disease across the globe. When ...
Breaking Medicine News(10 mins):Health News:US Sports Camps Football Camps Announce New Contact Football Camp Northeast Location 2Health News:Crawl Space FAQs are Answered in Clean Crawls Latest Article 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 2Health News:Narconon Arrowhead Promotes Local Prescription Drug Take Back Day 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 2Health News:Global Celiac Disease Market Counts on Drug Launch for Growth 3
... free time can promote headaches in children. This is ... study on risk factors, which appears in the current ... Arztebl Int 2009; 106[31-32]: 509-16). This investigation was ... and Headache" (Kinder, Jugendliche und KopfschmerzKiJuKo), in which data ...
... , , BOCA RATON, Fla., Aug. 17 ... com ), stays focused on what he knows inside and ... country about the newest techniques in cosmetic eyelid surgery. ... uptick of patients coming to him to correct and re-do blespharoplasties," said ...
... ... Week , ... Houston (Vocus) August 17, 2009 -- SuperSlow® Zone of Greater Houston has opened ... Katy Freeway, Suite 200 provides a one-on-one efficient, effective workout in a cool (68°), studio ...
... 17 After nearly four years of joint research of Houston-based ... Space Center (JSC), a senior NASA medical officer has confirmed that two ... by the astronauts of mission STS-125 of May 11, 2009 and the ... testing aboard the International Space Station. , , ...
... , , St. Jude ... lead survey of genome that identifies new genes linked to cancer risk ... 16 Scientists at St. Jude Children,s Research Hospital have identified inherited ... lymphoblastic leukemia (ALL), including a gene that may help predict drug response. ...
... online interventions now await , SUNDAY, Aug. 16 (HealthDay ... games and gossip, news and entertainment, essential information and ... as well. , A number of successful online medical ... quit smoking, lower their blood pressure and deal with ...
Cached Medicine News:Health News:Noted Cosmetic Eyelid Specialist, B. Bruce Myers MD FACS, Retains TransMedia Group to Promote His Vision 2Health News:SuperSlow Zone Opens in Bunker Hill Village 2Health News:Astronauts Test Use of Nutritional Supplements in Space 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 2Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 3Health News:Inherited Risk Factors Increase Odds of Developing Childhood Acute Lymphoblastic Leukemia 4Health News:Web Is Becoming One-Stop Shopping for Health Help 2Health News:Web Is Becoming One-Stop Shopping for Health Help 3
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... investigating the board of Salix Pharmaceuticals, Ltd. (NASDAQ: ... only $158.00 per share. Concerned SLXP investors are encouraged ... . The investigation focuses upon the ... proposed agreement, Salix shareholders would receive only $158.00 per ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... , WASHINGTON, Nov. 4 Sanford Wittels & Heisler, ... AtriCure, Inc., a medical device company specializing in cardiac ... with the Department of Justice (DOJ) in a qui ... interest over a five-year period. , Sanford Wittels & ...
... OAKS, Calif., Nov. 4 Amgen (Nasdaq: AMGN ... its 19th annual Amgen Award for Science Teaching Excellence ... honor extraordinary science teachers at the K-12 level who ... who achieve demonstrated results in student learning in communities ...
Cached Medicine Technology:Relator's Attorneys Comment On AtriCure/DOJ Proposed Settlement 2Call for Applications: The Amgen Award for Science Teaching Excellence 2Call for Applications: The Amgen Award for Science Teaching Excellence 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: